Lucid Diagnostics (LUCD) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free LUCD Stock Alerts $0.68 +0.01 (+1.49%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Lucid Diagnostics Stock Price Performance5 Day Performance-14.00%1 Month Performance-30.81%3 Month Performance-52.10%6 Month Performance-47.31%Year-To-Date Performance-51.42%1 Year Performance-54.33% Receive LUCD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lucid Diagnostics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. LUCD Stock Chart for Friday, April, 26, 2024 LUCD Chart by TradingView Lucid Diagnostics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024$0.68$0.67-1.90%$0.68$0.63235,339 shs$32.33 million04/24/2024$0.72$0.68-5.52%$0.73$0.67234,871 shs$32.95 million04/23/2024$0.75$0.72-3.70%$0.78$0.70269,451 shs$34.88 million04/22/2024$0.80$0.75-5.74%$0.82$0.74169,651 shs$36.22 million04/19/2024$0.80$0.80-0.44%$0.81$0.77118,112 shs$38.42 million04/18/2024$0.80$0.80-0.26%$0.81$0.7869,958 shs$38.60 million Get the Latest News and Ratings for LUCD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lucid Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024$0.82$0.80-1.58%$0.82$0.7937,557 shs$38.69 million04/16/2024$0.81$0.82+0.62%$0.82$0.7880,984 shs$39.32 million04/15/2024$0.81$0.81+0.12%$0.86$0.76363,063 shs$39.07 million04/12/2024$0.86$0.81-5.86%$0.88$0.78358,178 shs$39.03 million04/11/2024$0.92$0.86-6.75%$0.93$0.82302,476 shs$41.46 million04/10/2024$0.92$0.92$0.93$0.9051,147 shs$44.46 million04/09/2024$0.91$0.92+1.82%$0.93$0.9071,419 shs$44.46 million04/08/2024$0.93$0.91-2.44%$0.95$0.91181,226 shs$43.67 million04/05/2024$0.93$0.93-0.24%$0.95$0.9163,081 shs$44.75 million04/04/2024$0.92$0.93+1.19%$0.94$0.91158,438 shs$44.86 million04/03/2024$0.89$0.92+3.37%$0.92$0.87239,505 shs$44.33 million04/02/2024$0.90$0.89-1.00%$0.90$0.84192,820 shs$42.89 million04/01/2024$0.81$0.90+10.88%$0.92$0.85376,779 shs$43.32 million03/29/2024$0.81$0.81$1.00$0.811.02 million shs$39.07 million03/28/2024$0.99$0.81-18.19%$1.00$0.811.01 million shs$39.07 million03/27/2024$0.99$0.99$1.01$0.97493,218 shs$44.22 million03/26/2024$1.06$0.99-6.60%$1.06$0.97411,305 shs$44.22 million03/25/2024$1.09$1.06-2.75%$1.09$1.00168,508 shs$47.35 million03/22/2024$1.11$1.09-1.80%$1.11$1.03295,456 shs$48.69 million03/21/2024$1.11$1.11$1.19$1.04242,502 shs$49.58 million03/20/2024$1.08$1.11+2.78%$1.11$0.99444,685 shs$49.58 million03/19/2024$1.10$1.08-1.82%$1.08$1.03222,167 shs$48.24 million03/18/2024$1.11$1.10-0.90%$1.12$1.06157,478 shs$49.14 million03/15/2024$1.12$1.11-0.89%$1.14$1.04352,583 shs$49.58 million03/14/2024$1.22$1.12-8.20%$1.21$1.09157,800 shs$50.03 million03/13/2024$1.26$1.22-3.17%$1.27$1.1980,376 shs$54.50 million03/12/2024$1.26$1.26$1.28$1.2534,158 shs$56.28 million03/11/2024$1.29$1.26-2.33%$1.29$1.2282,119 shs$56.28 million03/08/2024$1.27$1.29+1.57%$1.30$1.20149,981 shs$57.62 million03/07/2024$1.26$1.27+0.79%$1.30$1.2354,098 shs$56.73 million03/06/2024$1.21$1.26+4.13%$1.26$1.1784,658 shs$56.28 million03/05/2024$1.22$1.21-0.82%$1.24$1.18147,230 shs$54.05 million03/04/2024$1.24$1.22-1.61%$1.26$1.17105,591 shs$54.50 million03/01/2024$1.23$1.24+0.81%$1.26$1.2098,679 shs$55.39 millionThe Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.02/29/2024$1.28$1.23-3.91%$1.32$1.21169,278 shs$54.94 million02/28/2024$1.27$1.28+0.79%$1.33$1.25113,702 shs$57.18 million02/27/2024$1.26$1.27+0.79%$1.29$1.24182,804 shs$56.73 million02/26/2024$1.24$1.26+1.61%$1.29$1.22207,764 shs$56.28 million02/23/2024$1.25$1.24-0.80%$1.25$1.2259,838 shs$55.39 million02/22/2024$1.29$1.25-3.10%$1.29$1.22120,920 shs$55.84 million02/21/2024$1.30$1.29-0.77%$1.30$1.23177,966 shs$57.62 million02/20/2024$1.36$1.30-4.41%$1.33$1.20185,177 shs$58.07 million02/19/2024$1.36$1.36$1.37$1.26234,400 shs$60.75 million02/16/2024$1.37$1.36-0.73%$1.37$1.26202,441 shs$60.75 million02/15/2024$1.34$1.37+2.24%$1.40$1.30281,217 shs$61.19 million02/14/2024$1.25$1.34+7.20%$1.35$1.2624,106 shs$59.86 million02/13/2024$1.25$1.25$1.28$1.2235,186 shs$55.84 million02/12/2024$1.30$1.25-3.85%$1.33$1.2052,997 shs$55.84 million02/09/2024$1.27$1.30+2.36%$1.31$1.2254,122 shs$58.07 million02/08/2024$1.32$1.27-3.79%$1.34$1.1487,756 shs$56.73 million02/07/2024$1.31$1.32+0.76%$1.35$1.2839,790 shs$58.96 million02/06/2024$1.44$1.31-9.03%$1.46$1.29104,070 shs$58.52 million02/05/2024$1.44$1.44$1.48$1.4020,137 shs$64.32 million02/02/2024$1.44$1.44$1.48$1.4034,628 shs$64.33 million02/01/2024$1.41$1.44+2.13%$1.45$1.3824,656 shs$64.33 million01/31/2024$1.40$1.41+0.71%$1.50$1.3732,778 shs$62.53 million01/30/2024$1.45$1.40-3.45%$1.50$1.3980,981 shs$62.54 million01/29/2024$1.43$1.45+1.40%$1.50$1.4258,310 shs$64.77 million01/26/2024$1.43$1.43$1.48$1.4030,566 shs$63.87 million01/25/2024$1.43$1.43$1.47$1.3942,600 shs$63.88 million Related Companies: ICU Stock Price Chart CODX Stock Price Chart CTCX Stock Price Chart CTSO Stock Price Chart DRIO Stock Price Chart MDAI Stock Price Chart LNSR Stock Price Chart MODD Stock Price Chart DXR Stock Price Chart RVP Stock Price Chart Receive LUCD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lucid Diagnostics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LUCD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.